Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam García-Arias

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?Alejandro Balsa, Miriam García-Arias
Best Practice & Research. Clinical Rheumatology|November 22, 2011
Septic arthritisMiriam García-Arias, Alejandro Balsa, Emilio Martín Mola
Reumatologia Clinica|March 14, 2018
Beekeeper' arthropathyCarolina Diez Morrondo, Lucía Pantoja Zarza, Pelayo Brañanova López, et al.
Reumatologia Clinica|September 20, 2011
[Rituximab in rheumatoid arthritis: a systematic review of efficacy and safety]Blanca Hernández-Cruz, Miriam García-Arias, Rafael Ariza Ariza, et al.
Rheumatology International|September 15, 2017
Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standardConcepción Castillo-Gallego, Eugenio De Miguel, Miriam García-Arias, et al.
Molecular Diagnosis & Therapy|January 19, 2013
Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohortMiriam García-Arias, Dora Pascual-Salcedo, Susana Ramiro, et al.
Reumatologia Clinica|July 29, 2011
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, et al.
Clinical and Experimental Rheumatology|February 22, 2019
Hyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) projectCarmen García-Gómez, María A Martín-Martínez, Cristina Fernández-Carballido, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?Alejandro Balsa, Miriam García-Arias
Best Practice & Research. Clinical Rheumatology|November 22, 2011
Septic arthritisMiriam García-Arias, Alejandro Balsa, Emilio Martín Mola
Reumatologia Clinica|March 14, 2018
Beekeeper' arthropathyCarolina Diez Morrondo, Lucía Pantoja Zarza, Pelayo Brañanova López, et al.
Reumatologia Clinica|September 20, 2011
[Rituximab in rheumatoid arthritis: a systematic review of efficacy and safety]Blanca Hernández-Cruz, Miriam García-Arias, Rafael Ariza Ariza, et al.
Rheumatology International|September 15, 2017
Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standardConcepción Castillo-Gallego, Eugenio De Miguel, Miriam García-Arias, et al.
Molecular Diagnosis & Therapy|January 19, 2013
Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohortMiriam García-Arias, Dora Pascual-Salcedo, Susana Ramiro, et al.
Reumatologia Clinica|July 29, 2011
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, et al.
Clinical and Experimental Rheumatology|February 22, 2019
Hyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) projectCarmen García-Gómez, María A Martín-Martínez, Cristina Fernández-Carballido, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Pageof 1